DCN Dx Names Trevor Brown Chief Revenue Officer

DCN Dx, an in vitro diagnostic (IVD) services company based in Carlsbad, California, has announced the appointment of Trevor Brown as Chief Revenue Officer. The company specializes in supporting the diagnostic path from concept to commercial success.

Brown has over 20 years of experience in commercial leadership within the diagnostics and life sciences sectors. He will be responsible for overseeing sales, marketing, and client growth across the company's three main areas: assay development and manufacturing, IVD-focused clinical trial and regulatory support, and biospecimen sourcing.

This appointment adds significant industry expertise to DCN Dx's Executive Leadership Team. Brown has previously held senior positions at companies such as LASE Innovation, LUMICKS, Spartan Bioscience, SeraCare Life Sciences, Luminex, and BD, and has a track record of launching multiple FDA- and CE-cleared IVDs.

Charlie Mamrak, CEO of DCN Dx, expressed enthusiasm for Brown's addition, highlighting his understanding of the diagnostics landscape and the challenges faced by customers. Brown stated that he joined DCN Dx to help partners bring transformative diagnostics to market more efficiently and effectively.

DCN Dx has been operating for over 20 years, providing essential services to assist companies in achieving commercial success for their diagnostic tests. The company manages three specialized businesses, with a focus on immunoassay and biospecimen collections, as well as IVD-focused clinical research organization services.